You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pirfenidone

Showing 1 - 25 of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial (BI 1015550, Nintedanib, Pirfenidone)

Not yet recruiting
  • Healthy
  • BI 1015550
  • +2 more
  • (no location specified)
Oct 2, 2023

Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +3 more
  • Pirfenidone
  • Placebo
  • Guangzhou, Guangdong, China
  • +4 more
Nov 16, 2023

Restrictive Chronic Lung Allograft Dysfunction, Lung Transplant Rejection Trial in San Francisco (Pirfenidone)

Completed
Has Results
  • Restrictive Chronic Lung Allograft Dysfunction
  • Lung Transplant Rejection
  • Pirfenidone
  • San Francisco, California
    University of California, San Francisco
Dec 13, 2022

Acute Respiratory Distress Syndrome (ARDS) Trial in Milan, Potenza (Pirfenidone, Placebo)

Recruiting
  • Acute Respiratory Distress Syndrome (ARDS)
  • Pirfenidone
  • Placebo
  • Milan, MI, Italy
  • +1 more
Dec 23, 2022

Pirfenidone, Connective Tissue Diseases, Interstitial Lung Disease Trial in Jinan (Pirfenidone, glucocorticoid and

Recruiting
  • Pirfenidone
  • +2 more
  • Pirfenidone
  • glucocorticoid and immunosuppressant
  • Jinan, Shandong, China
    Qilu Hospital
Aug 16, 2022

Novel Coronavirus-induced Lung Fibrosis Trial in Chandigarh (Pirfenidone, Nintedanib)

Active, not recruiting
  • Novel Coronavirus-induced Lung Fibrosis
  • Chandigarh, India
    Postgraduate Institute of Medical Education and Research
Sep 30, 2022

Covid19, ARDS Trial in Be'er Sheva (Pirfenidone, Standard of care)

Active, not recruiting
  • Covid19
  • ARDS
  • Pirfenidone
  • Standard of care
  • Be'er Sheva, Israel
    Soroka Medical Center
Jul 26, 2022

Healthy Trial in Neu-Ulm (Pirfenidone, GLPG4716, Nintedanib)

Completed
  • Healthy
  • Pirfenidone
  • +2 more
  • Neu-Ulm, Germany
    Nuvisan GmbH
Jun 1, 2022

Idiopathic Pulmonary Fibrosis Trial in Shanghai (HEC585, Pirfenidone, Nintedanib)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Shanghai, China
    Shanghai Xuhui Central Hospital
May 12, 2022

Asbestosis Trial (Pirfenidone)

Not yet recruiting
  • Asbestosis
  • Pirfenidone
  • (no location specified)
Nov 24, 2021

Dose Reduction and Discontinuation With Anti-Fibrotic

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Ridgefield, Connecticut
    Boehringer Ingelheim
Mar 24, 2023

Lung Cancer Trial in Wuhan (Pirfenidone)

Recruiting
  • Lung Cancer
  • Pirfenidone
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Mar 24, 2023

Chronic Kidney Disease Trial in San Diego, San Francisco (Pirfenidone, matching )

Recruiting
  • Chronic Kidney Disease
  • Pirfenidone
  • matching placebo
  • San Diego, California
  • +1 more
Apr 25, 2022

Fibrotic Pulmonary Sequelae Post-COVID19 Infection Trial in Spain (Pirfenidone, Placebo)

Recruiting
  • Fibrotic Pulmonary Sequelae Post-COVID19 Infection
  • Pirfenidone
  • Placebo
  • Hospitalet de Llobregat, Barcelona, Spain
  • +7 more
Dec 29, 2021

Idiopathic Pulmonary Fibrosis Trial in Seongnam-si (DWN12088, Pirfenidone, Nintedanib)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Seongnam-si, Korea, Republic of
    Cha Unitersity Bundang Medical Center
Sep 22, 2021

HF: Circulating Biomarkers of Fibrosis and Cardiovascular

Completed
  • Heart Failure With Preserved Ejection Fraction
  • Pirfenidone
  • Manchester, United Kingdom
    Manchester University NHS Foundation Trust
Apr 21, 2023

Based on Medical Records That Looks at Characteristics of

Completed
Has Results
  • Idiopathic Pulmonary Fibrosis
  • Plymouth, Pennsylvania
    Plymouth Meeting
Nov 12, 2021

Safety of Nintedanib in Real World in China

Not yet recruiting
  • Pulmonary Fibrosis
  • Beijing, China
    China-Japan Friendship Hospital
Jan 26, 2023

Pirfenidone, Connective Tissue Diseases, Interstitial Lung Disease Trial in Jinan (Pirfenidone, DMARDs)

Recruiting
  • Pirfenidone
  • +2 more
  • Jinan, Shandong, China
    Qilu Hospital
Jun 9, 2021

Interstitial Lung Disease Trial in Denver (Pirfenidone, Placebo controlled)

Completed
  • Interstitial Lung Disease
  • Pirfenidone
  • Placebo controlled
  • Denver, Colorado
    National Jewish Health
May 13, 2021

Pulmonary Fibrosis Trial in Paris (Pirfenidone)

Completed
  • Pulmonary Fibrosis
  • Pirfenidone
  • Paris, France
    Cochin Hospital
Apr 30, 2021

Rheumatoid Arthritis Interstitial Lung Disease Trial in Worldwide (Pirfenidone, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis Interstitial Lung Disease
  • Pirfenidone
  • Placebo
  • Birmingham, Alabama
  • +32 more
Jul 20, 2022

Idiopathic Pulmonary Fibrosis Trial in Beijing (HEC585, Pirfenidone, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Beijing, Beijing, China
    China-Japan Friendship Hospital
Sep 18, 2021

Idiopathic Pulmonary Fibrosis Trial in Russian Federation (Pirfenidone)

Completed
Has Results
  • Idiopathic Pulmonary Fibrosis
  • Pirfenidone
  • Barnaul, Altaj, Russian Federation
  • +10 more
Nov 18, 2020

Cardiac Failure Trial in Manchester (Pirfenidone, Placebo)

Completed
  • Cardiac Failure
  • Pirfenidone
  • Placebo
  • Manchester, Greater Manchester, United Kingdom
    Manchester University NHS Foundation Trust
Jul 1, 2020